Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

IL-4 receptor is a therapeutic target in atopic dermatitis

March 26, 2020

Pilot trial of botanical topical lotion CG-428 for permanent chemotherapy-induced alopecia

March 23, 2020

New pantetheinase inhibitors presented by Boehringer Ingelheim

March 16, 2020

Obschestvo S Ogranichennoi Otvetstvennostiyu "Z Therapeutics" divulges GC inhibitors

March 13, 2020

First phase I study of cannabinol cream INM-755 completes enrollment

March 11, 2020

BenevolentAI Bio divulges new NTRK1 inhibitors

March 6, 2020

Phase II data for nemolizumab in moderate-to-severe prurigo nodularis

March 4, 2020

Leo Pharma synthesizes new RORgammaT ligands

March 3, 2020

Increasing immune activity improves autoimmunity

March 3, 2020

Leo Pharma A/S presents RORC ligands

Feb. 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...